A cat is believed to have dialed 911 for owner, Gary Rosheisen, after he fell out of his wheelchair.

Officer Patrick Daugherty says, "I know it sounds kind of weird

Astellas Pharma U.S. Inc. says Friday that the FDA has approved a new drug for hospital patients suffering from life-threatening low sodium levels.

The drug, being marketed as Vaprisol, is intravenous and could be used to treat euvolemic hyponatremia, a condition that can occur in hospital patients suffering from afflictions like kidney failure, cancer, chronic high blood pressure and more

Astellas Pharma U.S. Inc. said Friday that the FDA has approved a new drug for hospital patients suffering from life-threatening low sodium levels.

The drug, being marketed as Vaprisol, is intravenous and could be used to treat euvolemic hyponatremia, which is a condition that can occur in hospital patients suffering from afflictions like kidney failure, cancer, chronic high blood pressure and more

Astellas Pharma U.S. Inc. said Friday that the FDA has approved a new drug for hospital patients suffering from life-threatening low sodium levels.

The drug, being marketed as Vaprisol, is intravenous and could be used to treat euvolemic hyponatremia, which is a condition that can occur in hospital patients suffering from afflictions like kidney failure, cancer, chronic high blood pressure and more

New research suggests Letrozole appears to be more effective than tamoxifen in reducing the likelihood of the recurrence of breast cancer.

Dr. Beat Thurlimann, of the Senalogy Center of Eastern Switzerland, and colleagues compared the outcomes of 8010 women randomly picked to one of four regimens for five years: letrozole; letrozole followed by tamoxifen; tamoxifen, or tamoxifen followed by letrozole